-
Study aim
-
Determining the effects of washing the nose with normal saline in the treatment of allergic rhinitis in children 6 to 12
-
Design
-
Randomized Clinical trial with control group, two parallel groups, children with allergic rhinitis aged 12–6 years divided two groups by block randomization method using Random allocation software
-
Settings and conduct
-
A study on children with allergic rhinitis referred to Urmia University of Medical Sciences' allergy clinics will be conducted, which will be randomly assigned to one of the two groups. The control group receives standard treatment (including oral antihistamine (1citrizine every 2 hours) and intranasal corticosteroids (Mometasone) every 12 hours), and the second group, in addition to standard treatment, nasal washes 4 times a day with a saline-soluble .65 % solution.
Signs such as sneezing, nasal runaway, nasal itching, nasal obstruction, itching palate, eye symptoms, and disruption to the daily activity and sleep of the patients will be collected before starting treatment and at intervals of one and three months using the RQLQ questionnaire.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
children with allergic rhinitis
aged 12–6 years
Parental Informed consent to participate in the study
Exclusion criteria: Non-allergic rhinitis, adenoid enlargement, infectious rhinitis, Concha Bollusa, intranasal meningocele, nasal polyp
-
Intervention groups
-
The control group receives standard treatment (including oral antihistamine (1citrizine every 2 hours) and intranasal corticosteroids (Mometasone) every 12 hours), and the second group, in addition to standard treatment, nasal washes 4 times a day with a saline-soluble .65 % solution.
-
Main outcome variables
-
Sneezing, nasal runaway, nasal itching, nasal obstruction, itching palate, eye symptoms, and disruption to the daily activity and sleep using the RQLQ questionnaire.